Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.DE Filed Acc 0001382963-15-000011

President and CEO gave up 119,842 shares (to pay taxes)

  • President and CEO acquired 372,756 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Riccitelli Samuel D · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-04-08 Exercise or conversion : show line 1 in the form +372,756 372,756 D
2015-04-08 Shares withheld for taxes : show line 2 in the form −119,842 $2.08 $249,271 252,914 D

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2015-04-08 Exercise or conversion : show line 3 in the form Restricted Stock Units −372,756 372,756 372,755 D
Loading xslF345X03/edgar.xml…